Biotech

All Articles

Sanofi fails MS research study, inflicting one more impact to Denali contract

.Sanofi has ceased a phase 2 difficulty of Denali Therapeutics-partnered oditrasertib in several scl...

Turnstone gives up 60%, shocks C-suite to stretch out cash

.Turnstone Biologics is reducing its headcount through 60% and agitating its own C-suite in order to...

Gilead quits on $15M MASH wager after weighing preclinical records

.In a year that has observed a permission as well as a plethora of readouts for metabolic dysfunctio...

Texas biotech centers cancer cells deal, pins wishes on obesity

.Alaunos Therapeutics is actually axing a deal along with Precigen, giving up licensing legal rights...

Capricor allotments more information for DMD therapy after starting BLA

.Capricor Rehabs is actually taking a victory lap for their period 2 Duchenne muscle dystrophy (DMD)...

FDA spots Kezar lupus trial in hold following 4 patient deaths

.The FDA has put Kezar Lifestyle Sciences' lupus trial on hold after the biotech flagged four fatali...

Phase 3 Intellectual Rock trial reaches SMA target, delivering stock up 200%

.A stage 3 trial of Intellectual Stone's spinal muscle degeneration (SMA) candidate has actually att...

CAMP 4 is actually most up-to-date to eye IPO, while Upstream describe $182M strategy

.RNA biotech CAMP4 Rehabs has defined think about a $67 thousand IPO, along with inflammation-focuse...

Galecto acquires leukemia medicine, falls bone tissue cancer property in pivot

.A year after the breakdown of an idiopathic lung fibrosis prospect delivered Galecto on a seek rede...

Judo throws down $100M to knock senseless renal disease

.Taking the floor covering is actually Judo Bio, an up-and-coming biotech armed with $100 million to...